Science and Technology Science and Technology
Wed, December 11, 2024
[ Wed, Dec 11th 2024 ] - The Economist
Machine translation is almost a solved problem. Making it perfect will be a hard problem
[ Wed, Dec 11th 2024 ] - The Economist
AI can bring back a person's own voice
[ Wed, Dec 11th 2024 ] - New Scientist
From enshittocene to virome, science and technology's words of 2024
[ Wed, Dec 11th 2024 ] - Daily Express
Microscopic bubble-like 'robots' could soon deliver drugs in the human body
[ Wed, Dec 11th 2024 ] - SciTech Daily
Revolutionary Microrobots Shrink Tumors in Groundbreaking Study
[ Wed, Dec 11th 2024 ] - The Economist
Carbon emissions from tourism are rising disproportionately fast
[ Wed, Dec 11th 2024 ] - MSN
Super-enzyme can enhance CO? capture in extreme conditions
[ Wed, Dec 11th 2024 ] - GMA Network
Senators 'sad, disappointed' over cuts in 2025 budget
[ Wed, Dec 11th 2024 ] - MSN
Understanding customer entry and exit in event-based journeys
[ Wed, Dec 11th 2024 ] - NextBigFuture
IBMs Using Largest Quantum Computers With Largest Supercomputers
[ Wed, Dec 11th 2024 ] - National Academies of Sciences%2c Engineering%2c and Medicine
Rural Areas Offer Unique Opportunities for STEM E .. eted Resources, Connectivity, and Training Needed
[ Wed, Dec 11th 2024 ] - MSN
Firefly Sparkle galaxy offers a taste of the infant Milky Way
[ Wed, Dec 11th 2024 ] - raf.mod.uk
Chinook crew from RAF Odiham inspire school students
[ Wed, Dec 11th 2024 ] - NextBigFuture
Nvidia Supports Artificial Intelligence for Quantum Computing
[ Wed, Dec 11th 2024 ] - Popular Mechanics
Mathematicians Casually Discovered Two New Infinities
[ Wed, Dec 11th 2024 ] - FOX59 News
State Board of Education approves changes to Indiana high school diploma requirements
[ Wed, Dec 11th 2024 ] - usace.army.mil
As Dr. Mark Dertzbaugh Retires, MRDC Honors His Thirty-Plus Years of Service
[ Wed, Dec 11th 2024 ] - The Daily Star
3 sent to jail in Pabna over gang-rape of PUST student
[ Wed, Dec 11th 2024 ] - MSN
"Steve Jobs, Corning Glass, and a Microscope"
[ Wed, Dec 11th 2024 ] - Nuclear Engineering International
Togo to establish Atomic Energy Commission
[ Wed, Dec 11th 2024 ] - IFLScience
Can You Crack The UK Spy Agency's Christmas Code-Breaking Challenge?
[ Wed, Dec 11th 2024 ] - MSN
People With More Will Power Have This Common Trait: Know What It Is
[ Wed, Dec 11th 2024 ] - Nature
Five countries having a clear impact on the latest materials-science research
[ Wed, Dec 11th 2024 ] - MSN
How to segment traffic from LLMs in GA4
[ Wed, Dec 11th 2024 ] - Yen.com.gh
Hilda Abena Wilson: Ghanaian Lady's Academic Brilliance Honoured at UCC Graduation Ceremony
[ Wed, Dec 11th 2024 ] - MSN
Dartmouth students build and code robots in STEM challenge
[ Wed, Dec 11th 2024 ] - MSN
Japan unveils AI-powered human washing machine at Expo 2025
[ Wed, Dec 11th 2024 ] - Yahoo
'Naked, animal terror': Why The Stone Tape is the most chilling Christmas special ever made
[ Wed, Dec 11th 2024 ] - MSN
UK military successfully tests laser weapons for shooting down UAVs
[ Wed, Dec 11th 2024 ] - MSN
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript


Published on 2024-12-11 08:42:25 - MSN
  Print publication without navigation

  • Q2 2025 Earnings Call Transcript December 10, 2024 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.07. Operator: Good morning, ladies and gentlemen,

The article provides a transcript of the Q2 2025 earnings call for ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA). During the call, CEO Dr. Jennifer Bath discussed the company's financial performance, highlighting a revenue increase to $6.7 million, up 17% from the previous year, driven by growth in their BioStrand and Talem segments. She also mentioned the company's strategic focus on enhancing their AI-driven drug discovery platform, LENSai, which aims to accelerate the development of therapeutic antibodies. Dr. Bath outlined plans for expanding their service offerings, improving operational efficiencies, and advancing their proprietary technology. The call also covered updates on ongoing partnerships, new client engagements, and the company's outlook for the remainder of the fiscal year, emphasizing continued investment in technology and innovation to drive future growth.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/technology/biotechnology/immunoprecise-antibodies-ltd-nasdaq-ipa-q2-2025-earnings-call-transcript/ar-AA1vFmlO ]
Contributing Sources